It is demonstrated that inhibition of these protein kinases significantly suppresses the growth of UM spheroids exposed to both X-rays and PBT, which is primarily driven by delayed and persistent DSBs, leading to the accumulation of chromosomal aberrations.
Laura Hawkins, R. Morris, H. Kalirai et al.· Frontiers in Oncology· 0 citations
The current ATM, ATR, DNA-PK, CHK1, CHK2 and WEE1 inhibitors that show the most promise as monotherapies and combination treatments in solid tumours are discussed, as well as the potential benefits of using TPD technology over small-molecule inhibitors.
Lauryn Buckley-Benbow, Antonia M. Rout, Andrew B. Fielding et al.· TARGETS· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.